• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随着开放科学的兴起,我们是否需要一个澳大拉西亚 PubMed 中心(PMC)?一项定性研究。

With open science gaining traction, do we need an Australasia PubMed Central (PMC)? A qualitative investigation.

机构信息

Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia.

出版信息

PLoS One. 2019 Feb 22;14(2):e0212843. doi: 10.1371/journal.pone.0212843. eCollection 2019.

DOI:10.1371/journal.pone.0212843
PMID:30794701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6386259/
Abstract

Open biomedical repositories, such as PubMed Central (PMC), are a means to make research discoverable and permanently accessible. Assessing the potential interest of key stakeholders in an Australasia PubMed Central was the objective of this research. The investigation is novel, assisting in the development of open science infrastructure through its systematic analysis of the potential interest in, and viability of a biomedical repository for managing openly accessible research outputs for the Australasia region. The research adopted a qualitative approach based on semi-structured interviews and a focus group. Forty-four stakeholders located throughout Australia and New Zealand participated in the research. Participants expanded upon their experience of PubMed, MEDLINE, PMC and their use of information resources for research and clinical practice. The Evidence Based Healthcare (EBHC) pyramid was the theoretical model adopted to explain open biomedical repository processes. A strengths, weaknesses, opportunities and threats (SWOT) analysis identified support for exploring membership of an international PMC system, in particular Europe PMC. Lessons learnt from PMC US, Europe PMC and PMC Canada (collectively known as PubMed Central International) informed the investigation. A major strength identified was that PubMed Central International has been able to achieve high levels of compliance way beyond that of most institutional repositories. A great threat faced is overcoming the difficulties of working together with other major world bodies and financially sustaining an Australasia PMC. Improving Australasian biomedical knowledge management processes may be possible from adopting a PMC for retrieving and transferring research, linked to the data underlying the research. This in turn could help put regional research under a brighter spotlight, potentially leading to improvements in research quality. There is an opportunity for a potential Australasia PMC to harvest biomedical research from the National Library of Australia's aggregator database, Trove and work closely with Europe PMC to avoid duplication of effort. Overall, establishment of an Australasia permanent biomedical digital open repository is perceived as important, with significant potential flow-on benefits to healthcare, industry and society.

摘要

开放的生物医学知识库,如 PubMed Central(PMC),是使研究可发现和永久获取的一种手段。本研究旨在评估澳大利亚和太平洋地区 PMC 的主要利益相关者对其潜在兴趣。通过对开放获取研究成果进行管理的生物医学知识库的潜在利益和可行性进行系统分析,该研究具有创新性,有助于开发开放科学基础设施。该研究采用基于半结构化访谈和焦点小组的定性方法。来自澳大利亚和新西兰各地的 44 名利益相关者参与了这项研究。参与者详细介绍了他们在 PubMed、MEDLINE、PMC 方面的经验,以及他们在研究和临床实践中使用信息资源的情况。循证医疗保健(EBHC)金字塔是解释开放生物医学知识库流程的理论模型。强弱、机会和威胁(SWOT)分析确定了支持探索加入国际 PMC 系统的机会,特别是欧洲 PMC。从 PMC US、欧洲 PMC 和 PMC Canada(统称为 PubMed Central International)吸取的经验教训为调查提供了信息。确定的一个主要优势是,PubMed Central International 能够实现远远超过大多数机构知识库的高水平合规性。面临的一个巨大威胁是克服与其他主要世界机构合作的困难,并在财务上维持一个澳大利亚太平洋 PMC。通过采用 PMC 来检索和转移研究,与研究背后的数据相关联,可能会改善澳大利亚的生物医学知识管理流程。这反过来又可以帮助将区域研究置于更明亮的聚光灯下,从而有可能提高研究质量。澳大利亚太平洋 PMC 有机会从澳大利亚国家图书馆的聚合器数据库 Trove 中获取生物医学研究,并与欧洲 PMC 密切合作,避免重复工作。总体而言,建立一个澳大利亚太平洋永久生物医学数字开放知识库被认为是重要的,这对医疗保健、工业和社会将产生重大的潜在影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18d/6386259/18718860827d/pone.0212843.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18d/6386259/18718860827d/pone.0212843.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b18d/6386259/18718860827d/pone.0212843.g001.jpg

相似文献

1
With open science gaining traction, do we need an Australasia PubMed Central (PMC)? A qualitative investigation.随着开放科学的兴起,我们是否需要一个澳大拉西亚 PubMed 中心(PMC)?一项定性研究。
PLoS One. 2019 Feb 22;14(2):e0212843. doi: 10.1371/journal.pone.0212843. eCollection 2019.
2
Exploring PubMed as a reliable resource for scholarly communications services.探索将PubMed作为学术交流服务的可靠资源。
J Med Libr Assoc. 2019 Jan;107(1):16-29. doi: 10.5195/jmla.2019.433. Epub 2019 Jan 1.
3
Searching and Evaluating Publications and Preprints Using Europe PMC.利用 Europe PMC 搜索和评估出版物及预印本
Curr Protoc. 2023 Mar;3(3):e694. doi: 10.1002/cpz1.694.
4
Europe PMC in 2020.欧洲 PMC 于 2020 年。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1507-D1514. doi: 10.1093/nar/gkaa994.
5
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
6
Risk management frameworks for human health and environmental risks.人类健康与环境风险的风险管理框架。
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608.
7
Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.制药政策制定面临的挑战:来自澳大利亚国家药品政策的经验教训。
Aust Health Rev. 2014 May;38(2):160-8. doi: 10.1071/AH13240.
8
Professional regulation for Australasian genetic counselors.澳大利亚和亚洲遗传咨询师专业规范
J Genet Couns. 2021 Apr;30(2):361-369. doi: 10.1002/jgc4.1344. Epub 2020 Nov 5.
9
A research roadmap for complementary and alternative medicine - what we need to know by 2020.补充和替代医学研究路线图——到2020年我们需要了解的内容。
Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.
10
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.

引用本文的文献

1
Predicting the number of citations of polycystic kidney disease with 100 top-cited articles since 2010: Bibliometric analysis.预测 2010 年以来 100 篇高引多囊肾病文献的被引频次:文献计量学分析。
Medicine (Baltimore). 2022 Sep 23;101(38):e30632. doi: 10.1097/MD.0000000000030632.
2
Predicting the number of article citations in the field of attention-deficit/hyperactivity disorder (ADHD) with the 100 top-cited articles since 2014: a bibliometric analysis.利用2014年以来被引频次最高的100篇文章预测注意力缺陷多动障碍(ADHD)领域的文章被引次数:一项文献计量分析。
Ann Gen Psychiatry. 2021 Jan 21;20(1):6. doi: 10.1186/s12991-021-00329-3.

本文引用的文献

1
Do authors comply when funders enforce open access to research?当资助者强制要求研究成果开放获取时,作者会遵守规定吗?
Nature. 2018 Oct;562(7728):483-486. doi: 10.1038/d41586-018-07101-w.
2
The state of OA: a large-scale analysis of the prevalence and impact of Open Access articles.开放获取(OA)的现状:对开放获取文章的患病率和影响的大规模分析。
PeerJ. 2018 Feb 13;6:e4375. doi: 10.7717/peerj.4375. eCollection 2018.
3
Discriminating Between Legitimate and Predatory Open Access Journals: Report from the International Federation for Emergency Medicine Research Committee.
区分合法与掠夺性开放获取期刊:国际急诊医学联合会研究委员会报告
West J Emerg Med. 2016 Sep;17(5):497-507. doi: 10.5811/westjem.2016.7.30328. Epub 2016 Aug 8.
4
EBHC pyramid 5.0 for accessing preappraised evidence and guidance.用于获取预先评估的证据和指南的循证卫生保健金字塔5.0
Evid Based Med. 2016 Aug;21(4):123-5. doi: 10.1136/ebmed-2016-110447. Epub 2016 Jun 20.
5
Countries' Biomedical Publications and Attraction Scores. A PubMed-based assessment.各国的生物医学出版物及吸引力得分。基于PubMed的评估。
F1000Res. 2014 Dec 1;3:292. doi: 10.12688/f1000research.5775.2. eCollection 2014.
6
Europe PMC: a full-text literature database for the life sciences and platform for innovation.欧洲生物医学与健康科学电子图书馆(Europe PMC):一个生命科学领域的全文文献数据库及创新平台。
Nucleic Acids Res. 2015 Jan;43(Database issue):D1042-8. doi: 10.1093/nar/gku1061. Epub 2014 Nov 6.
7
Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap.实时系统评价:缩小证据-实践差距的新契机。
PLoS Med. 2014 Feb 18;11(2):e1001603. doi: 10.1371/journal.pmed.1001603. eCollection 2014 Feb.
8
The great contribution: Index Medicus, Index-Catalogue, and IndexCat.巨大贡献:《医学索引》《索引目录》和《索引编目》。
J Med Libr Assoc. 2009 Apr;97(2):108-13. doi: 10.3163/1536-5050.97.2.007.
9
Of studies, syntheses, synopses, and systems: the "4S" evolution of services for finding current best evidence.论研究、综述、概要及体系:获取当前最佳证据服务的“4S”演变
ACP J Club. 2001 Mar-Apr;134(2):A11-3.
10
PubMed Central: The GenBank of the published literature.PubMed 中央数据库:已发表文献的基因库。
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):381-2. doi: 10.1073/pnas.98.2.381.